Salute e Benessere

Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals

Industry analysts at Exactitude Consultancy project the cancer immunotherapy market will reach $258.22 billion by 2031[3], driven by breakthrough treatment platforms and precision technologies that are transforming how tumors are detected and destroyed. The convergence of FDA fast-track approvals, revolutionary immune-based treatments, and innovative therapeutic approaches creates optimal conditions for companies positioned at the forefront of next-generation cancer care. Industry analysts at...
PR Newswire
16/09/2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 37 - 2025

Aggregated presentation by day and by marketStatement of transactions in own shares from September 08th to September 12th 2025 Name of the issueIdentity code of the issuer(Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code)IPSEN549300M6SGDPB4Z94P1108/09/2025FR0010259150300...
Nasdaq GlobeNewswire
16/09/2025

OXURION : Axiodis CRO, the French subsidiary of the Oxurion Group, announces a…

• Launch of digital twins and virtual patients to accelerate and enhance clinical trials • Integration of AI modules into Exagis, Axiodis' proprietary eCRF solution Leuven, BELGIUM, September 16, 2025, 6:00 PM – Oxurion NV (Euronext Brussels: OXUR) announces that its subsidiary, Axiodis CRO, specialized in clinical data management, is developing…
Actusnews Wire
16/09/2025

OXURION : Axiodis CRO, de Franse dochtervennootschap van de Oxurion-groep…

• Lancering van digitale tweelingen en virtuele patiënten om klinische studies te versnellen en te beveiligen • Integratie van AI-modules in Exagis, de eigen eCRF-oplossing van Axiodis Leuven, BELGIË, 16 september 2025, 18u00 – Oxurion NV (Euronext Brussel: OXUR) kondigt aan dat zijn dochtervennootschap Axiodis CRO, gespecialiseerd in klinische…
Actusnews Wire
16/09/2025

Antlara Dental unveils timeless white

Timeless White is not just a colour choice; it also represents an aesthetic approach. When deciding to offer this option, Antlara Dental takes into account the material's light transmission and the patient's skin tone, as different materials—such as zirconia, porcelain, or metal-supported porcelain—can display varying shades, requiring patient trials to determine the best match. Following treatment, this helps patients feel more confident both physically and emotionally. A common theme in…
PR Newswire
16/09/2025

Sterilization Services Market worth $5.49 billion by 2030 with 7.9% CAGR |…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183597324 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183597324 Browse in-depth TOC on "Sterilization Services Market" 350 - Tables 45 - Figures 300 - Pages By method,the sterilization services market has been segmented into ethylene oxide (EtO) sterilization, gamma sterilization, electron-beam (E-beam) radiation sterilization, X-ray irradiation...
PR Newswire
16/09/2025

/C O R R E C T I O N -- Disney Consumer Products/

LONDON, Sept. 16, 2025 /PRNewswire/ -- As the 100-day countdown to Christmas begins, Selfridges and Disney announce an unprecedented festive collaboration to excite and enchant visitors from around the world. LONDON , Sept. 16, 2025 /PRNewswire/ --As the 100-day countdown to Christmas begins, Selfridges and Disney announce an unprecedented festive collaboration to excite and enchant visitors from around the world. 'A Most Magical Christmas' is inspired by timeless Disney stories...
PR Newswire
16/09/2025

Connected Health Market is Projected To Reach US$421.5 Billion By 2031 With CAGR…

Therefore, the report from The Insight Partners provides several stakeholders—including raw material/component provider, connected health market manufacturers, government agencies, regulatory bodies, and end users —valuable insights into navigating this evolving market landscape and successfully unlocking new opportunities. Therefore, the report from The Insight Partners provides several stakeholders—including raw material/component provider, connected health market manufacturers, government...
PR Newswire
16/09/2025

Latin America Infusion Pump Market worth US$1.00 billion by 2030 with 6.2% CAGR…

Browse in-depth TOC on "Latin America Infusion Pump Market" Browse in-depth TOC on "Latin America Infusion Pump Market" 259 - Tables 60 - Figures 297 - Pages By product,the market is segmented into accessories & consumables and devices. Several interrelated factors propel the consumption of consumables & accessories in the market. The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders necessitates continuous and precise...
PR Newswire
16/09/2025

Medical Device OEM/ODM/CDMO Industry Forecast: CAGR of 7.5% to 2031 Amid Growing…

The global market for Medical Device OEM/ODM/CDMO was valued at US$ 115434 million in the year 2024 and is projected to reach a revised size of US$ 191760 million by 2031, growing at a CAGR of 7.5% during the forecast period. The global market for Medical Device OEM/ODM/CDMO was valued atUS$ 115434 millionin the year 2024 and is projected to reach a revised size ofUS$ 191760 millionby 2031, growing at a CAGR of 7.5% during the forecast period. Download Free Sample Data on Medical...
PR Newswire
16/09/2025

Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring…

"The Accu-Chek SmartGuide CGM solution is a significant step towards providing greater peace of mind for people living with diabetes, due to the AI-enabled predictive capabilities it offers. This empowers patients to take action before undesired events occur," said Rodrigo Diaz de Vivar, Lifecycle Leader Patient Insights, Roche Diagnostics. "By bringing together our Accu-Chek SmartGuide solution with mySugr, we are combining our predictive CGM technology with one of the world's…
PR Newswire
16/09/2025

EQT Life Sciences portfolio company VarmX partners with CSL in a strategic…

VMX-C001 is an investigational product, designed to bypass the FXa anticoagulation activity and swiftly restore coagulation in patients in urgent surgery and severe bleeding situations. Under the terms of the strategic collaboration agreement, CSL will fully fund VarmX's global Phase 3 trial evaluating VMX-C001. CSL will also fully fund and support VarmX in late-stage product development, manufacturing and pre-launch commercial and medical affairs activities. VMX-C001 is an investigational...
PR Newswire
16/09/2025

Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of…

Piramal Pharma Solutions has prioritized safety and quality throughout implementation of the XM-12 at the Morpeth facility, instituting comprehensive training protocols to ensure proper handling of the equipment. Piramal Pharma Solutions has prioritized safety and quality throughout implementation of the XM-12 at theMorpethfacility, instituting comprehensive training protocols to ensure proper handling of the equipment. "In preparation for using the Korsch XM-12, Piramal's scientists,...
PR Newswire
16/09/2025

ALCOR Scientific Transforms ESR Testing: Extends Blood Sample Stability from 4…

One of the most widely ordered blood tests in the world, ESR helps clinicians detect and monitor infections, autoimmune conditions, certain cancers and other diseases. Once collected, blood samples for ESR need to be tested or refrigerated within four hours to maintain their accuracy. This can be challenging in today's laboratory environment, where samples travel long distances without refrigeration and often experience delays, which can lead to compromised results. One of the most widely...
PR Newswire
16/09/2025

AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum…

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com PHOENIX and LONDON, Sept.16, 2025(GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB:ACUT ), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, today announced that Wendy Blosser, CEO, will present live at the Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences...
Nasdaq GlobeNewswire
16/09/2025

Caristo Congratulates Abcentra for First Patient Dosed Successfully in Phase 2b…

TheFORTIFYclinical trial ( Focused Orticumab Research for Treating Inflammation in Coronary Arteries ; NCT06927739) is a multi-center, randomized, placebo-controlled, double-blind trial designed to evaluate the efficacy of orticumab in reducing local coronary inflammation in patients with a history of type 1 myocardial infarction (MI) and elevated coronary inflammation. A total of 240 adults with a history of type 1 MI and elevated Fat Attenuation Index (FAI) Score — determined...
PR Newswire
16/09/2025

Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide…

Positive results show that the average weight loss was 12.5 kg (11.8% body weight reduction) with cagrilintide compared to 2.5 kg (2.3%) with placebo, after 68 weeks *1 ,2 Cagrilintide was well-tolerated, with the most common side effects being gastrointestinal; these were mainly transient and mild to moderate in severity 1 Based on these results, Novo Nordisk will advance cagrilintide into the dedicated RENEW phase 3 clinical programme later this year Bagsværd, Denmark, 16...
Nasdaq GlobeNewswire
16/09/2025

Israeli Med-Tech Delegation Builds Bridges in Romania's Healthcare System

Israeli companies presented a wide range of pioneering technologies: drones for medical delivery, wearable sexual health devices, digital pathology, biotech therapies, lab information systems, automated compounding, AI-driven protocol reviews, and smart mobility solutions for seniors. The lineup included GADFIN, Virility Medical, Contel Group, Augmentiqs, GHF-Pharma, Softov Medical Systems (LabOS), Equashield, ELMAR, and SitnStand. Israeli companies presented a wide range of pioneering...
PR Newswire
16/09/2025

BIOVAXYS ANNOUNCES CLOSING OF UNSECURED CONVERTIBLE DEBENTURE OFFERING

The Debentures are unsecured obligations of the Company, mature August 30, 2026 (the "Maturity Date"), and bear interest at a rate of 10% per annum with such interest payable on a quarterly basis in either cash or, at the sole discretion of the Company, in common shares of the Company ("Shares"). The principal outstanding under the Debentures will be convertible into Shares at any time, at the option of the holder, at the closing price of the Shares on the Canadian Securities…
PR Newswire
16/09/2025

Manchester charity recognises UK hero volunteers

Human Appeal’s Purple Legacy Awards returned for the second year Purple Legacy Awards 2025, that recentlytook place. The first was organised in 2024 to celebrate the selfless work of the charity’s network of volunteers nationwide.With 16 awards categories on the evening, thePurple Legacy Awardstakes inspiration from the charity’s purple logo and motto, ‘here for every human’. The idea of legacy is at the heart of the ceremony and Human Appeal’s work transforming lives at home and...
Nasdaq GlobeNewswire
16/09/2025

New Scientific Review Highlights β-Lactoglobulin's Dual Benefits for Metabolic…

BLG's dual benefits BLG's dual benefits Rich in leucine and capable of generating bioactive peptides during digestion, BLG offers a rare combination of metabolic and muscle-preserving benefits – two of the most pressing nutrition challenges in ageing and metabolic health. The review highlights several features that set BLG apart. It contains 1.5 times more leucine than standard whey or casein, providing a strong trigger for muscle protein synthesis. BLG ensures sustained amino acid...
PR Newswire
16/09/2025

Trident Group Deepens MENA Footprint with AED 6 million Investment at Sleep Expo…

At Sleep Expo ME 2025, held from 15-17 September at Sheikh Saeed Hall 1–3 & Trade Centre Arena, Dubai World Trade Centre, Trident showcased its full range including Bed & Bath Linen, My Trident, Yarn, Paper, and Bathrobes. Sleep Expo Middle East is MENA's largest and most influential event dedicated to the sleep, mattress, and bedding industry. The central theme of the showcase was the 20th anniversary of Trident's patented Air Rich® technology, a pioneering textile innovation inspired…
PR Newswire
16/09/2025

New Study Finds Pycnogenol® Alleviates Cellulite in Women

Published in Phytomedicine Plus, the study evaluated 60 women aged 25 to 45 years over the course of three months, with cellulite status and response measured at baseline, 4 weeks, 8 weeks, and 12 weeks. Thirty (30) women took 150 mg of Pycnogenol® a day (50 mg in the morning and 100 mg in the evening), while thirty (30) women took a placebo. Key findings include: Published in Phytomedicine Plus , the study evaluated 60 women aged 25 to 45 years over the course of three months, with...
PR Newswire
16/09/2025

Cantoni Therapeutics secures financing to advance novel non-incretin obesity…

Brabant Development Agency (BOM) and angel investor join lead investor Libertatis Ergo Holding (LEH) in providing funding, with additional financial support from Brabant Startup Fund (BSF)Cantoni awarded validatioNN grant from Novo Nordisk to support disease-relevant translational research on NNMT, a novel target for cardiometabolic diseases, including obesity and its comorbiditiesOSS, Netherlands, September 16, 2025 - Cantoni Therapeutics B.V. (‘Cantoni’), a biotech company spun...
Nasdaq GlobeNewswire
16/09/2025
Altri  Comunicati